1989
DOI: 10.1007/bf00265547
|View full text |Cite
|
Sign up to set email alerts
|

Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes

Abstract: Summary. Many patients with Type 2 (non-insulin-dependent) diabetes mellitus are treated with insulin in order to control hyperglycaemia. We studied fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and 24 h urinary Cpeptide in relation to clinical type of diabetes in 132 insulin treated diabetic subjects. Patients were classified clinically as Type 1 (insulin-dependent) diabetic subjects in the presence of at least two of the following criteria: 1) significant ketonuria, 2)insulin treatment star… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
52
0
1

Year Published

1994
1994
2016
2016

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 94 publications
(56 citation statements)
references
References 34 publications
3
52
0
1
Order By: Relevance
“…Diabetes was classified as either type 1 or type 2 diabetes mellitus on clinical grounds (WHO Report 1985). Where classification was difficult, a glucagon-stimulated C-peptide level was measured to distinguish between type 1 and type 2 diabetes (Gjessing et al 1989). Secondary diabetes was diagnosed when an obvious and verified cause, such as pancreatitis, was found.…”
Section: Methodsmentioning
confidence: 99%
“…Diabetes was classified as either type 1 or type 2 diabetes mellitus on clinical grounds (WHO Report 1985). Where classification was difficult, a glucagon-stimulated C-peptide level was measured to distinguish between type 1 and type 2 diabetes (Gjessing et al 1989). Secondary diabetes was diagnosed when an obvious and verified cause, such as pancreatitis, was found.…”
Section: Methodsmentioning
confidence: 99%
“…Diabetes was classified as either type 1 or type 2 diabetes mellitus on clinical grounds (WHO Study Group 1985). Where classification was difficult, a glucagon-stimulated C-peptide level was measured to distinguish between type 1 and type 2 diabetes (Gjessing et al 1989). Secondary diabetes was diagnosed when an obvious and verified cause, such as pancreatitis, was found.…”
Section: Patientsmentioning
confidence: 99%
“…P values of less than 0.05 were considered statistically significant. gon injection (glucagon test) was introduced more than a decade ago as a measure of pancreatic responsiveness in type 1 diabetes [4,5] and T2D [5][6][7][8][9]. The glucagon test has also been used in attempts to discriminate whether T2D-patients require insulin for hyperglycemic control [8].…”
Section: Discussionmentioning
confidence: 99%